0001415889-24-017799.txt : 20240621 0001415889-24-017799.hdr.sgml : 20240621 20240621145700 ACCESSION NUMBER: 0001415889-24-017799 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240618 FILED AS OF DATE: 20240621 DATE AS OF CHANGE: 20240621 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pimblett Emily CENTRAL INDEX KEY: 0001969365 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40708 FILM NUMBER: 241059750 MAIL ADDRESS: STREET 1: C/O ELIEM THERAPEUTICS, INC. STREET 2: 23515 NE NOVELTY HILL RD, STE B221 #125 CITY: REDMOND STATE: WA ZIP: 98053 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Eliem Therapeutics, Inc. CENTRAL INDEX KEY: 0001768446 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 832273741 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2801 CENTERVILLE ROAD 1ST FLOOR STREET 2: PMB #117 CITY: WILMINGTON STATE: DE ZIP: 19808 BUSINESS PHONE: 877-354-3689 MAIL ADDRESS: STREET 1: 2801 CENTERVILLE ROAD 1ST FLOOR STREET 2: PMB #117 CITY: WILMINGTON STATE: DE ZIP: 19808 4 1 form4-06212024_060656.xml X0508 4 2024-06-18 0001768446 Eliem Therapeutics, Inc. ELYM 0001969365 Pimblett Emily C/O ELIEM THERAPEUTICS, INC. WILMINGTON DE 19808 false true false false CHIEF ACCOUNTING OFFICER 0 Common Stock 2024-06-18 4 M 0 5000 A 5000 D Common Stock 2024-06-20 4 S 0 1245 7.2145 D 3755 D Restricted Stock Units 2024-06-18 4 M 0 5000 0 D Common Stock 5000 35000 D Each restricted stock unit ("RSU") converted into one share of the Issuer's Common Stock. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The shares subject to this RSU shall vest at a rate of 1/8th of the total number of shares on the three-month anniversary of March 18, 2024 (the "March 2024 Vesting Commencement Date") and 1/8th of the total number of shares each three-month anniversary of the March 2024 Vesting Commencement Date thereafter for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the two-year anniversary of the March 2024 Vesting Commencement Date. /s/ William Cowles, Attorney-in-Fact 2024-06-21